Compare FUL & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FUL | BLLN |
|---|---|---|
| Founded | 1887 | 2016 |
| Country | United States | United States |
| Employees | N/A | 713 |
| Industry | Home Furnishings | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.9B |
| IPO Year | 2007 | N/A |
| Metric | FUL | BLLN |
|---|---|---|
| Price | $61.52 | $98.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $68.40 | ★ $126.71 |
| AVG Volume (30 Days) | 512.5K | ★ 739.9K |
| Earning Date | 03-25-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | ★ 19.57 | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $2,897,000,000.00 | N/A |
| Revenue This Year | $4.96 | $46.29 |
| Revenue Next Year | $4.00 | $30.14 |
| P/E Ratio | $164.76 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $48.71 | $61.96 |
| 52 Week High | $68.63 | $138.70 |
| Indicator | FUL | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 53.06 | 57.84 |
| Support Level | $57.30 | $79.07 |
| Resistance Level | $65.49 | $97.36 |
| Average True Range (ATR) | 2.19 | 7.26 |
| MACD | 0.42 | 0.66 |
| Stochastic Oscillator | 64.86 | 82.61 |
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.